Specialised Therapeutics' breast cancer drug gets Philippines FDA approval - Pharmaceutical Technology
7/8/2022 12:00:00 AM2 years 9 months ago
by Vishnu Priyan
by Vishnu Priyan
Specialised Therapeutics’ oral drug, Nerlynx (neratinib) has obtained the Philippines Food and Drug Administration approval to lower the recurrence or mortality risk in early-stage HER2-posi
Specialised Therapeutics oral drug, Nerlynx (neratinib) has obtained the Philippines Food and Drug Administration approval to lower the recurrence or mortality risk in early-stage HER2-positive (HER2… [+2029 chars]
full article...